文献速递胸部CT

基于大小区域矩阵的影像组学特征对肺腺癌预后的增量获益:肿瘤评估中空间分区的优势

Incremental benefits of size-zone matrix-based radiomics features for the prognosis of lung adenocarcinoma: advantage of spatial partitioning on tumor evaluation.
PubMed 文献 · Eur Radiol · 2022-05-12

研究纳入298例肺腺癌患者,分析治疗前CT图像,采用五折交叉验证构建总生存风险模型,比较7种模型的风险比。结果显示,影像组学特征联合SZM特征(HR 4.034)优于单用影像组学特征(HR 3.439),且联合临床变量后SZM特征的增量获益仍保持(HR 6.524 优于 4.202)。

要点

  • SZM特征与影像组学特征联合较单用影像组学特征提高预后风险区分(HR 4.034 对 3.439)。
  • 联合SZM特征、影像组学特征和临床变量的模型风险比最高(HR 6.524)。
  • SZM特征在加入临床变量后仍保持增量预后获益。

核心结论

  • SZM特征联合影像组学特征优于单用影像组学特征,且在加入临床变量后SZM特征的增量获益仍保持,证实SZM特征对肺腺癌预后具有增量获益。

研究设计与样本

  • 研究纳入298例肺腺癌患者,分析治疗前CT图像,采用五折交叉验证,构建并比较7种总生存风险模型,以测试折上的风险比(HR)评估模型。

诊断标准与关键数值

  • 临床变量风险模型作为基线,HR为2.739。
  • 影像组学特征单用模型HR为3.439,影像组学特征联合SZM特征模型HR为4.034。
  • 影像组学特征联合临床变量模型HR为4.202,联合影像组学特征、SZM特征和临床变量模型HR为6.524。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Prognostic models of lung adenocarcinoma (ADC) can be built using radiomics features from various categories. The size-zone matrix (SZM) features have a strong biological basis related to tumor partitioning, but their incremental benefits have not been fully explored. In our study, we aimed to evaluate the incremental benefits of SZM features for the prognosis of lung ADC.

METHODS: A total of 298 patients were included and their pretreatment computed tomography images were analyzed in fivefold cross-validation. We built a risk model of overall survival using SZM features and compared it with a conventional radiomics risk model and a clinical variable-based risk model. We also compared it with other models incorporating various combinations of SZM features, other radiomics features, and clinical variables. A total of seven risk models were compared and evaluated using the hazard ratio (HR) on the left-out test fold.

RESULTS: As a baseline, the clinical variable risk model showed an HR of 2.739. Combining the radiomics signature with SZM feature was better (HR 4.034) than using radiomics signature alone (HR 3.439). Combining radiomics signature, SZM feature, and clinical variable (HR 6.524) fared better than just combining radiomics signature and clinical variables (HR 4.202). These results confirmed the added benefits of SZM features for prognosis in lung ADC.

CONCLUSION: Combining SZM feature with the radiomics signature was better than using the radiomics signature alone and the benefits of SZM features were maintained when clinical variables were added confirming the incremental benefits of SZM features for lung ADC prognosis.

KEY POINTS: • Size-zone matrix (SZM) features provide incremental benefits for the prognosis of lung adenocarcinoma. • Combining the radiomics signature with SZM features performed better than using a radiomics signature alone.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim, Lee, Lee, et al. Incremental benefits of size-zone matrix-based radiomics features for the prognosis of lung adenocarcinoma: advantage of spatial partitioning on tumor evaluation. Eur Radiol. 2022. PMID: 35554645. doi:10.1007/s00330-022-08818-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。